Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for WRNIP1
Z-value: 1.89
Motif logo
Transcription factors associated with WRNIP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WRNIP1
|
ENSG00000124535.11 | WRN helicase interacting protein 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| WRNIP1 | hg19_v2_chr6_+_2765595_2765797 | -0.24 | 2.1e-01 | Click! |
Activity profile of WRNIP1 motif
Sorted Z-values of WRNIP1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51471381 | 22.81 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51504852 | 20.97 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
| chr19_-_51471362 | 19.12 |
ENST00000376853.4
ENST00000424910.2 |
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51472031 | 16.42 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51466681 | 14.26 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_+_35645817 | 13.12 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr19_+_35645618 | 13.00 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr19_-_51456344 | 12.95 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
| chr19_-_51487282 | 11.62 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
| chr19_-_51504411 | 11.27 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
| chr19_-_51487071 | 10.34 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
| chr1_-_205391178 | 10.12 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
| chr19_-_51456321 | 9.88 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
| chr19_-_51472823 | 9.64 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51472222 | 8.98 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr8_-_7274385 | 8.78 |
ENST00000318157.2
|
DEFB4B
|
defensin, beta 4B |
| chr8_-_23261589 | 8.70 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
| chr19_-_51845378 | 8.08 |
ENST00000335624.4
|
VSIG10L
|
V-set and immunoglobulin domain containing 10 like |
| chr7_+_157318477 | 7.69 |
ENST00000444154.1
|
AC006372.1
|
AC006372.1 |
| chr1_-_205419053 | 7.64 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
| chr1_-_28503693 | 7.63 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
| chr7_-_41740181 | 7.06 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
| chr12_-_25055949 | 6.56 |
ENST00000539282.1
|
BCAT1
|
branched chain amino-acid transaminase 1, cytosolic |
| chr19_-_51456198 | 6.33 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
| chr15_-_90039805 | 6.30 |
ENST00000544600.1
ENST00000268122.4 |
RHCG
|
Rh family, C glycoprotein |
| chr19_-_19051993 | 6.24 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr20_+_33759854 | 5.96 |
ENST00000216968.4
|
PROCR
|
protein C receptor, endothelial |
| chr1_+_20915409 | 5.93 |
ENST00000375071.3
|
CDA
|
cytidine deaminase |
| chrX_-_38080077 | 5.86 |
ENST00000378533.3
ENST00000544439.1 ENST00000432886.2 ENST00000538295.1 |
SRPX
|
sushi-repeat containing protein, X-linked |
| chr19_-_19051927 | 5.73 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
| chr12_+_53491220 | 5.66 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
| chr2_-_31637560 | 5.65 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
| chr1_+_32042131 | 5.64 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr1_-_20812690 | 5.55 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr18_+_47088401 | 5.52 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
| chr19_-_55658281 | 5.47 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr1_-_204116078 | 5.31 |
ENST00000367198.2
ENST00000452983.1 |
ETNK2
|
ethanolamine kinase 2 |
| chr19_-_51014345 | 5.28 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
| chr14_-_94443105 | 5.11 |
ENST00000555019.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr19_-_51537982 | 4.98 |
ENST00000525263.1
|
KLK12
|
kallikrein-related peptidase 12 |
| chr16_-_84651673 | 4.98 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
| chrX_-_107019181 | 4.96 |
ENST00000315660.4
ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family, member 3 |
| chr19_+_38826477 | 4.87 |
ENST00000409410.2
ENST00000215069.4 |
CATSPERG
|
catsper channel auxiliary subunit gamma |
| chr19_-_36019123 | 4.83 |
ENST00000588674.1
ENST00000452271.2 ENST00000518157.1 |
SBSN
|
suprabasin |
| chr19_-_51014460 | 4.82 |
ENST00000595669.1
|
JOSD2
|
Josephin domain containing 2 |
| chr1_-_24469602 | 4.78 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
| chr8_+_7752151 | 4.76 |
ENST00000302247.2
|
DEFB4A
|
defensin, beta 4A |
| chr20_-_52790055 | 4.75 |
ENST00000395955.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
| chr2_-_113594279 | 4.74 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
| chr9_+_33795533 | 4.65 |
ENST00000379405.3
|
PRSS3
|
protease, serine, 3 |
| chr22_+_38071615 | 4.64 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
| chr11_-_123065989 | 4.60 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
| chr22_+_31488433 | 4.45 |
ENST00000455608.1
|
SMTN
|
smoothelin |
| chr20_-_52790512 | 4.41 |
ENST00000216862.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
| chr2_+_64681219 | 4.39 |
ENST00000238875.5
|
LGALSL
|
lectin, galactoside-binding-like |
| chr6_-_30654977 | 4.39 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
| chr17_+_39969183 | 4.35 |
ENST00000321562.4
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
| chr6_+_151561506 | 4.34 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr19_+_54371114 | 4.32 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
| chr2_+_228678550 | 4.29 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
| chr6_+_151561085 | 4.27 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr11_-_111783595 | 4.25 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr5_-_127873659 | 4.19 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
| chr12_+_8975061 | 4.17 |
ENST00000299698.7
|
A2ML1
|
alpha-2-macroglobulin-like 1 |
| chr8_+_22022800 | 4.15 |
ENST00000397814.3
|
BMP1
|
bone morphogenetic protein 1 |
| chr14_-_94421923 | 4.11 |
ENST00000555507.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr1_+_32042105 | 4.08 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr8_+_54793425 | 4.08 |
ENST00000522225.1
|
RGS20
|
regulator of G-protein signaling 20 |
| chr1_+_17531614 | 4.05 |
ENST00000375471.4
|
PADI1
|
peptidyl arginine deiminase, type I |
| chr4_-_57524061 | 4.03 |
ENST00000508121.1
|
HOPX
|
HOP homeobox |
| chr20_-_43280325 | 4.03 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
| chr1_+_150522222 | 4.03 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
| chr11_-_2160180 | 4.00 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr6_+_86159821 | 3.98 |
ENST00000369651.3
|
NT5E
|
5'-nucleotidase, ecto (CD73) |
| chr19_+_54926601 | 3.98 |
ENST00000301194.4
|
TTYH1
|
tweety family member 1 |
| chr8_+_54793454 | 3.97 |
ENST00000276500.4
|
RGS20
|
regulator of G-protein signaling 20 |
| chr6_+_150263136 | 3.95 |
ENST00000367351.3
|
ULBP2
|
UL16 binding protein 2 |
| chr7_+_100770328 | 3.94 |
ENST00000223095.4
ENST00000445463.2 |
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
| chr1_+_152957707 | 3.93 |
ENST00000368762.1
|
SPRR1A
|
small proline-rich protein 1A |
| chr15_-_74495188 | 3.92 |
ENST00000563965.1
ENST00000395105.4 |
STRA6
|
stimulated by retinoic acid 6 |
| chr9_+_125137565 | 3.91 |
ENST00000373698.5
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
| chr7_+_145813453 | 3.84 |
ENST00000361727.3
|
CNTNAP2
|
contactin associated protein-like 2 |
| chr12_-_57630873 | 3.83 |
ENST00000556732.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr4_-_57522470 | 3.82 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
| chrX_-_107018969 | 3.79 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
| chr3_-_13921594 | 3.77 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
| chr11_+_124735282 | 3.77 |
ENST00000397801.1
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila) |
| chr4_-_175443484 | 3.77 |
ENST00000514584.1
ENST00000542498.1 ENST00000296521.7 ENST00000422112.2 ENST00000504433.1 |
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr15_-_75017711 | 3.75 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
| chr5_-_149682447 | 3.75 |
ENST00000328668.7
|
ARSI
|
arylsulfatase family, member I |
| chr14_-_75079026 | 3.73 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
| chr19_-_36004543 | 3.72 |
ENST00000339686.3
ENST00000447113.2 ENST00000440396.1 |
DMKN
|
dermokine |
| chr19_-_11689752 | 3.72 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr1_-_153521597 | 3.71 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
| chr16_-_84651647 | 3.67 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
| chr12_-_47473425 | 3.67 |
ENST00000550413.1
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr19_+_917287 | 3.64 |
ENST00000592648.1
ENST00000234371.5 |
KISS1R
|
KISS1 receptor |
| chr6_+_86159765 | 3.63 |
ENST00000369646.3
ENST00000257770.3 |
NT5E
|
5'-nucleotidase, ecto (CD73) |
| chr17_+_4736627 | 3.62 |
ENST00000355280.6
ENST00000347992.7 |
MINK1
|
misshapen-like kinase 1 |
| chr17_+_7942424 | 3.61 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
| chr17_+_42081914 | 3.60 |
ENST00000293404.3
ENST00000589767.1 |
NAGS
|
N-acetylglutamate synthase |
| chr21_-_28217721 | 3.60 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
| chr1_-_113498616 | 3.58 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr19_+_51152702 | 3.57 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
| chr12_+_4382917 | 3.56 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
| chr19_+_45409011 | 3.55 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr20_-_44540686 | 3.52 |
ENST00000477313.1
ENST00000542937.1 ENST00000372431.3 ENST00000354050.4 ENST00000420868.2 |
PLTP
|
phospholipid transfer protein |
| chr6_+_151662815 | 3.52 |
ENST00000359755.5
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr2_+_210288760 | 3.52 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
| chr1_+_203651937 | 3.52 |
ENST00000341360.2
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
| chr9_+_128509624 | 3.49 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr5_+_7654057 | 3.49 |
ENST00000537121.1
|
ADCY2
|
adenylate cyclase 2 (brain) |
| chr7_-_24797032 | 3.48 |
ENST00000409970.1
ENST00000409775.3 |
DFNA5
|
deafness, autosomal dominant 5 |
| chr11_+_125496619 | 3.46 |
ENST00000532669.1
ENST00000278916.3 |
CHEK1
|
checkpoint kinase 1 |
| chr13_+_110959598 | 3.45 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
| chr1_-_153029980 | 3.43 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
| chr11_-_66675371 | 3.43 |
ENST00000393955.2
|
PC
|
pyruvate carboxylase |
| chr2_-_70780572 | 3.39 |
ENST00000450929.1
|
TGFA
|
transforming growth factor, alpha |
| chr1_-_93426998 | 3.38 |
ENST00000370310.4
|
FAM69A
|
family with sequence similarity 69, member A |
| chr10_+_88718397 | 3.38 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr16_+_55512742 | 3.38 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
| chr2_-_216300784 | 3.37 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
| chr17_-_43209862 | 3.36 |
ENST00000322765.5
|
PLCD3
|
phospholipase C, delta 3 |
| chr19_+_39687596 | 3.36 |
ENST00000339852.4
|
NCCRP1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
| chr7_-_93519471 | 3.35 |
ENST00000451238.1
|
TFPI2
|
tissue factor pathway inhibitor 2 |
| chr12_-_54813229 | 3.35 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr16_-_85784557 | 3.34 |
ENST00000602675.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
| chr11_-_2158507 | 3.33 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr17_+_40610862 | 3.33 |
ENST00000393829.2
ENST00000546249.1 ENST00000537728.1 ENST00000264649.6 ENST00000585525.1 ENST00000343619.4 ENST00000544137.1 ENST00000589727.1 ENST00000587824.1 |
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1 |
| chr19_-_51014588 | 3.32 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
| chr2_+_233925064 | 3.31 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
| chr19_-_51538148 | 3.30 |
ENST00000319590.4
ENST00000250351.4 |
KLK12
|
kallikrein-related peptidase 12 |
| chr19_-_51327034 | 3.29 |
ENST00000301420.2
ENST00000448701.2 |
KLK1
|
kallikrein 1 |
| chrX_-_48328631 | 3.28 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
| chr8_-_21999362 | 3.28 |
ENST00000334530.5
ENST00000518664.1 |
REEP4
|
receptor accessory protein 4 |
| chr7_+_40174565 | 3.26 |
ENST00000309930.5
ENST00000401647.2 ENST00000335693.4 ENST00000413931.1 ENST00000416370.1 ENST00000540834.1 |
C7orf10
|
succinylCoA:glutarate-CoA transferase |
| chr10_+_88718314 | 3.25 |
ENST00000348795.4
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr1_-_113478603 | 3.25 |
ENST00000443580.1
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr5_+_150400124 | 3.24 |
ENST00000388825.4
ENST00000521650.1 ENST00000517973.1 |
GPX3
|
glutathione peroxidase 3 (plasma) |
| chr8_-_133097902 | 3.24 |
ENST00000262283.5
|
OC90
|
Otoconin-90 |
| chr7_+_100547156 | 3.21 |
ENST00000379458.4
|
MUC3A
|
Protein LOC100131514 |
| chr19_+_45281118 | 3.21 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chrX_-_48325857 | 3.21 |
ENST00000376875.1
|
SLC38A5
|
solute carrier family 38, member 5 |
| chrX_+_41192595 | 3.20 |
ENST00000399959.2
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
| chr9_+_35829208 | 3.18 |
ENST00000439587.2
ENST00000377991.4 |
TMEM8B
|
transmembrane protein 8B |
| chr1_-_153521714 | 3.17 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
| chr19_-_55658687 | 3.16 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr16_+_66638003 | 3.14 |
ENST00000562357.1
ENST00000360086.4 ENST00000562707.1 ENST00000361909.4 ENST00000460097.1 ENST00000565666.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr4_-_57547454 | 3.13 |
ENST00000556376.2
|
HOPX
|
HOP homeobox |
| chr4_-_80994619 | 3.12 |
ENST00000404191.1
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr14_+_24867992 | 3.12 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr9_-_123639304 | 3.11 |
ENST00000436309.1
|
PHF19
|
PHD finger protein 19 |
| chr15_-_74504597 | 3.11 |
ENST00000416286.3
|
STRA6
|
stimulated by retinoic acid 6 |
| chr3_-_98620500 | 3.10 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
| chr9_+_128509663 | 3.09 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr1_-_17307173 | 3.09 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
| chr22_+_30792846 | 3.09 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr15_-_74504560 | 3.08 |
ENST00000449139.2
|
STRA6
|
stimulated by retinoic acid 6 |
| chr19_-_36001286 | 3.08 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
| chr19_+_38826415 | 3.08 |
ENST00000410018.1
ENST00000409235.3 |
CATSPERG
|
catsper channel auxiliary subunit gamma |
| chr4_-_175443788 | 3.07 |
ENST00000541923.1
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr10_+_75670862 | 3.06 |
ENST00000446342.1
ENST00000372764.3 ENST00000372762.4 |
PLAU
|
plasminogen activator, urokinase |
| chr2_-_241396131 | 3.06 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
| chr19_-_51512804 | 3.06 |
ENST00000594211.1
ENST00000376832.4 |
KLK9
|
kallikrein-related peptidase 9 |
| chr17_-_36981556 | 3.03 |
ENST00000536127.1
ENST00000225428.5 |
CWC25
|
CWC25 spliceosome-associated protein homolog (S. cerevisiae) |
| chr19_-_51538118 | 3.03 |
ENST00000529888.1
|
KLK12
|
kallikrein-related peptidase 12 |
| chr2_+_113816685 | 3.03 |
ENST00000393200.2
|
IL36RN
|
interleukin 36 receptor antagonist |
| chr2_-_42991257 | 3.02 |
ENST00000378661.2
|
OXER1
|
oxoeicosanoid (OXE) receptor 1 |
| chr19_-_43269809 | 3.01 |
ENST00000406636.3
ENST00000404209.4 ENST00000306511.4 |
PSG8
|
pregnancy specific beta-1-glycoprotein 8 |
| chr16_-_85784718 | 3.00 |
ENST00000602766.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
| chr9_+_34653861 | 3.00 |
ENST00000556792.1
ENST00000318041.9 ENST00000378817.4 |
IL11RA
|
interleukin 11 receptor, alpha |
| chr2_+_95691445 | 2.99 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
| chr19_-_51017881 | 2.99 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
| chr2_+_64681103 | 2.97 |
ENST00000464281.1
|
LGALSL
|
lectin, galactoside-binding-like |
| chr15_+_63335899 | 2.97 |
ENST00000561266.1
|
TPM1
|
tropomyosin 1 (alpha) |
| chr14_-_23834411 | 2.96 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
| chr9_-_21305312 | 2.94 |
ENST00000259555.4
|
IFNA5
|
interferon, alpha 5 |
| chr12_+_119616447 | 2.93 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
| chr19_-_42916499 | 2.93 |
ENST00000601189.1
ENST00000599211.1 |
LIPE
|
lipase, hormone-sensitive |
| chr1_+_152486950 | 2.93 |
ENST00000368790.3
|
CRCT1
|
cysteine-rich C-terminal 1 |
| chr17_+_40704938 | 2.93 |
ENST00000225929.5
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1 |
| chr22_-_37640456 | 2.91 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr15_+_63481668 | 2.91 |
ENST00000321437.4
ENST00000559006.1 ENST00000448330.2 |
RAB8B
|
RAB8B, member RAS oncogene family |
| chr3_+_47324424 | 2.90 |
ENST00000437353.1
ENST00000232766.5 ENST00000455924.2 |
KLHL18
|
kelch-like family member 18 |
| chr10_+_102106829 | 2.89 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
| chr15_-_74501360 | 2.88 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
| chr15_-_34659349 | 2.88 |
ENST00000314891.6
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
| chr5_-_39219705 | 2.88 |
ENST00000351578.6
|
FYB
|
FYN binding protein |
| chr12_-_25055177 | 2.88 |
ENST00000538118.1
|
BCAT1
|
branched chain amino-acid transaminase 1, cytosolic |
| chr9_-_33167308 | 2.87 |
ENST00000535206.1
ENST00000379731.4 |
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
| chr2_-_208030647 | 2.86 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr9_+_35673853 | 2.85 |
ENST00000378357.4
|
CA9
|
carbonic anhydrase IX |
| chr1_-_153013588 | 2.85 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
| chr17_-_76899275 | 2.85 |
ENST00000322630.2
ENST00000586713.1 |
DDC8
|
Protein DDC8 homolog |
| chr12_-_122238464 | 2.83 |
ENST00000546227.1
|
RHOF
|
ras homolog family member F (in filopodia) |
| chr5_-_60140009 | 2.83 |
ENST00000505959.1
|
ELOVL7
|
ELOVL fatty acid elongase 7 |
| chr12_+_4385230 | 2.83 |
ENST00000536537.1
|
CCND2
|
cyclin D2 |
| chr4_-_80994471 | 2.82 |
ENST00000295465.4
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr5_+_156887027 | 2.82 |
ENST00000435489.2
ENST00000311946.7 |
NIPAL4
|
NIPA-like domain containing 4 |
| chrX_-_48328551 | 2.81 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
Network of associatons between targets according to the STRING database.
First level regulatory network of WRNIP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.5 | 51.0 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 8.3 | 24.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 4.3 | 94.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 3.9 | 31.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 3.8 | 11.4 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 3.5 | 14.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 3.2 | 9.6 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 3.1 | 9.4 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 3.0 | 5.9 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 2.9 | 8.6 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 2.7 | 13.4 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 2.5 | 4.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 2.4 | 9.4 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 2.3 | 6.9 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 2.3 | 6.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 2.1 | 6.2 | GO:2000283 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 2.0 | 2.0 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 2.0 | 8.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 2.0 | 12.0 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 1.9 | 5.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 1.8 | 1.8 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 1.8 | 1.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 1.8 | 10.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.8 | 5.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 1.6 | 4.9 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.6 | 1.6 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 1.6 | 6.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 1.6 | 6.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.6 | 7.8 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.5 | 4.6 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.5 | 9.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.5 | 4.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 1.5 | 13.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.5 | 4.5 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.5 | 5.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.5 | 7.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.5 | 8.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 1.5 | 4.4 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 1.4 | 7.1 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 1.4 | 4.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 1.4 | 1.4 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
| 1.4 | 4.2 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 1.4 | 4.1 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.4 | 1.4 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 1.4 | 6.9 | GO:0060301 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 1.4 | 5.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 1.3 | 6.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 1.3 | 6.6 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
| 1.3 | 5.3 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 1.3 | 6.6 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.3 | 10.5 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 1.3 | 3.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.3 | 5.2 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 1.3 | 3.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.3 | 5.1 | GO:2000685 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 1.3 | 1.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 1.2 | 1.2 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 1.2 | 1.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 1.2 | 4.9 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.2 | 4.9 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.2 | 2.4 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 1.2 | 6.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 1.2 | 30.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 1.2 | 1.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 1.2 | 1.2 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 1.2 | 4.7 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 1.2 | 5.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 1.1 | 1.1 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 1.1 | 2.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.1 | 3.4 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 1.1 | 1.1 | GO:0014015 | positive regulation of gliogenesis(GO:0014015) regulation of glial cell differentiation(GO:0045685) |
| 1.1 | 2.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) cellular response to growth hormone stimulus(GO:0071378) |
| 1.1 | 1.1 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 1.1 | 1.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 1.1 | 3.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.1 | 1.1 | GO:1901205 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 1.1 | 1.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 1.1 | 3.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 1.0 | 1.0 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) positive regulation of sperm motility(GO:1902093) |
| 1.0 | 1.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 1.0 | 2.1 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 1.0 | 7.3 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 1.0 | 3.1 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.0 | 9.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.0 | 4.1 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 1.0 | 3.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.0 | 5.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 1.0 | 6.0 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.0 | 10.0 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 1.0 | 6.0 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.0 | 1.0 | GO:1903202 | negative regulation of oxidative stress-induced cell death(GO:1903202) |
| 1.0 | 2.9 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 1.0 | 5.8 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 1.0 | 1.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.9 | 10.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.9 | 2.8 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.9 | 6.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.9 | 6.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.9 | 7.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.9 | 3.6 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 0.9 | 1.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.9 | 7.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.9 | 8.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.9 | 3.5 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.9 | 7.7 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.9 | 3.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.9 | 6.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.9 | 7.7 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.9 | 5.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.8 | 6.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.8 | 0.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.8 | 1.7 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.8 | 12.6 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.8 | 2.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.8 | 2.5 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
| 0.8 | 2.5 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.8 | 3.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.8 | 3.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.8 | 1.6 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 0.8 | 3.2 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.8 | 4.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.8 | 4.0 | GO:1990834 | response to odorant(GO:1990834) |
| 0.8 | 3.2 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.8 | 1.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.8 | 2.4 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.8 | 3.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.8 | 2.4 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.8 | 2.4 | GO:0030070 | insulin processing(GO:0030070) |
| 0.8 | 0.8 | GO:0090345 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.8 | 3.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.8 | 2.3 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.8 | 2.3 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.8 | 13.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.8 | 0.8 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
| 0.8 | 2.3 | GO:0043318 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.8 | 2.3 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 0.8 | 2.3 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.8 | 4.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.7 | 3.0 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.7 | 6.0 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.7 | 3.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.7 | 0.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.7 | 0.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.7 | 2.2 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.7 | 12.4 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.7 | 5.8 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.7 | 21.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.7 | 0.7 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
| 0.7 | 2.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.7 | 1.4 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.7 | 2.2 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.7 | 12.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.7 | 2.9 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.7 | 5.0 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.7 | 5.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.7 | 2.1 | GO:0048627 | myoblast development(GO:0048627) |
| 0.7 | 2.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.7 | 2.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.7 | 0.7 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.7 | 2.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.7 | 3.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.7 | 2.7 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.7 | 0.7 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.7 | 0.7 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.7 | 6.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.7 | 4.7 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.7 | 2.0 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.7 | 5.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
| 0.7 | 6.1 | GO:0046618 | drug export(GO:0046618) |
| 0.7 | 10.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.7 | 2.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.7 | 5.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.7 | 2.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.7 | 0.7 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.7 | 3.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.6 | 1.9 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.6 | 2.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.6 | 1.9 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.6 | 0.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.6 | 3.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.6 | 9.6 | GO:0001660 | fever generation(GO:0001660) |
| 0.6 | 1.9 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.6 | 5.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.6 | 1.9 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.6 | 0.6 | GO:1903923 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.6 | 1.9 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 0.6 | 4.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.6 | 2.5 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.6 | 5.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.6 | 3.7 | GO:0014028 | notochord formation(GO:0014028) |
| 0.6 | 0.6 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 0.6 | 1.2 | GO:0007622 | rhythmic behavior(GO:0007622) |
| 0.6 | 0.6 | GO:0045575 | basophil activation(GO:0045575) |
| 0.6 | 1.8 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.6 | 1.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.6 | 0.6 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
| 0.6 | 2.4 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.6 | 1.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 0.6 | 3.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.6 | 1.8 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.6 | 2.4 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.6 | 0.6 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.6 | 2.9 | GO:0060356 | leucine import(GO:0060356) |
| 0.6 | 6.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.6 | 5.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.6 | 6.9 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.6 | 2.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.6 | 1.7 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.6 | 1.7 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.6 | 5.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.6 | 1.1 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.6 | 2.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.6 | 9.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.6 | 1.1 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.6 | 2.3 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.6 | 0.6 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.6 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.6 | 0.6 | GO:0030432 | peristalsis(GO:0030432) |
| 0.6 | 7.9 | GO:0015816 | glycine transport(GO:0015816) |
| 0.6 | 1.1 | GO:1904640 | response to methionine(GO:1904640) |
| 0.6 | 9.4 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.6 | 1.1 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.6 | 2.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.5 | 2.7 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.5 | 2.2 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.5 | 0.5 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.5 | 6.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.5 | 1.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.5 | 2.2 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.5 | 10.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.5 | 1.6 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.5 | 9.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.5 | 3.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.5 | 1.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.5 | 2.7 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.5 | 2.1 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.5 | 0.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.5 | 3.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.5 | 2.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.5 | 1.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.5 | 2.6 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.5 | 3.2 | GO:0030421 | defecation(GO:0030421) |
| 0.5 | 1.6 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.5 | 2.6 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.5 | 2.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.5 | 1.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.5 | 1.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.5 | 3.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.5 | 2.6 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.5 | 1.6 | GO:1904351 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.5 | 12.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.5 | 4.7 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.5 | 4.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.5 | 1.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.5 | 6.7 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
| 0.5 | 7.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.5 | 2.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.5 | 1.0 | GO:0015820 | leucine transport(GO:0015820) |
| 0.5 | 3.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.5 | 2.0 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.5 | 0.5 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.5 | 2.0 | GO:0046671 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.5 | 4.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 0.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.5 | 1.5 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.5 | 2.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.5 | 4.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.5 | 2.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.5 | 1.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.5 | 5.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.5 | 1.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.5 | 1.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.5 | 1.5 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.5 | 5.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.5 | 3.4 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.5 | 5.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.5 | 1.9 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.5 | 1.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.5 | 2.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.5 | 1.0 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.5 | 1.4 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.5 | 6.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 3.8 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.5 | 6.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.5 | 1.4 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.5 | 0.9 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.5 | 1.4 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.5 | 2.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.5 | 1.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.5 | 2.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.5 | 1.4 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.5 | 0.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.5 | 1.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.5 | 0.5 | GO:0042161 | regulation of lipoprotein oxidation(GO:0034442) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.5 | 0.9 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.5 | 1.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.5 | 1.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.5 | 1.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 0.5 | 1.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.5 | 0.5 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
| 0.5 | 1.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.5 | 0.9 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.5 | 0.9 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.5 | 5.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.5 | 1.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.5 | 4.1 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.5 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.5 | 2.3 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 0.5 | 2.7 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 | 3.2 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.5 | 2.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.5 | 2.7 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.5 | 0.5 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.5 | 7.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.4 | 1.3 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.4 | 0.9 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.4 | 0.9 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.4 | 8.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.4 | 0.9 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.4 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 0.9 | GO:1902275 | regulation of chromatin organization(GO:1902275) |
| 0.4 | 0.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.4 | 1.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.4 | 2.2 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.4 | 11.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.4 | 3.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 | 4.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.4 | 1.8 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.4 | 1.3 | GO:0050894 | determination of affect(GO:0050894) |
| 0.4 | 1.8 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.4 | 0.9 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.4 | 5.3 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.4 | 2.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.4 | 0.9 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
| 0.4 | 3.1 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.4 | 1.7 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.4 | 1.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.4 | 1.7 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.4 | 3.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.4 | 1.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.4 | 1.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.4 | 2.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 | 6.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.4 | 2.6 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.4 | 3.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.4 | 2.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.4 | 0.4 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
| 0.4 | 3.0 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.4 | 3.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.4 | 4.2 | GO:0030903 | notochord development(GO:0030903) |
| 0.4 | 1.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.4 | 0.8 | GO:0072376 | protein activation cascade(GO:0072376) |
| 0.4 | 5.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.4 | 0.4 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.4 | 1.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.4 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.4 | 2.1 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.4 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 | 2.1 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 | 1.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.4 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.4 | 1.7 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.4 | 0.8 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.4 | 1.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 0.4 | 1.2 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.4 | 1.6 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.4 | 1.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.4 | 5.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 | 3.3 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.4 | 1.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 | 1.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.4 | 2.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.4 | 3.2 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.4 | 2.0 | GO:0048749 | compound eye development(GO:0048749) |
| 0.4 | 1.6 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.4 | 0.4 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.4 | 2.4 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.4 | 2.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.4 | 0.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.4 | 0.8 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.4 | 0.4 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.4 | 0.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.4 | 2.0 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.4 | 3.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.4 | 0.8 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.4 | 3.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.4 | 1.2 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.4 | 1.2 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.4 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
| 0.4 | 0.4 | GO:0051604 | protein maturation(GO:0051604) |
| 0.4 | 4.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.4 | 1.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.4 | 1.6 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.4 | 2.3 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.4 | 0.4 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
| 0.4 | 5.8 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.4 | 3.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.4 | 4.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.4 | 7.7 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.4 | 1.2 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 0.4 | 0.4 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.4 | 1.5 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.4 | 4.6 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.4 | 1.5 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 | 0.8 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.4 | 4.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.4 | 9.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.4 | 1.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.4 | 4.2 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.4 | 1.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.4 | 0.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.4 | 1.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.4 | 0.4 | GO:0007272 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
| 0.4 | 0.4 | GO:0071706 | tumor necrosis factor superfamily cytokine production(GO:0071706) |
| 0.4 | 1.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 | 42.3 | GO:0070268 | cornification(GO:0070268) |
| 0.4 | 0.7 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.4 | 3.0 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.4 | 0.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.4 | 1.5 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.4 | 1.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.4 | 1.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.4 | 1.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.4 | 1.9 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.4 | 0.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.4 | 2.6 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.4 | 1.1 |